Seeking to license a patented therapeutic and drug delivery system

Peabody Pharmaceuticals
Peabody Pharmaceuticals

We fight to provide relief to TENS OF millions who suffer from acute PAIN

We fight to provide relief to TENS OF millions who suffer from acute PAINWe fight to provide relief to TENS OF millions who suffer from acute PAINWe fight to provide relief to TENS OF millions who suffer from acute PAIN

Our solution is a non-divertible, safe, and effective opiate 

Innovative Solutions

At Peabody Pharmaceuticals, we are dedicated to developing innovative solutions for healthcare challenges. Our focus is on creating effective and safe pharmaceutical products that improve patient outcomes.


Our Services

Our Services

Our Services

Established Analgesic 

Translate a FDA approved and effective

veterinary opioid analgesic, Ethiqa XR®, to

treat human pain with a much lower risk of

abuse than other opioids

 

Delivery Method

Combine the non-addictive opioid,

buprenorphine, with a lipid carrier system

Our Team

Our Services

Our Services

Our team is made up of experienced professionals who are dedicated to providing extensive R&D, comprehensive patient care, and outstanding service to the tens of millions who suffer from acute pain annually

Our Vision

Our Services

Our Vision

Peabody is fighting to provide relief to tens of millions of Americans who suffer from acute pain annually and to reduce abuse, addictions, and overdose deaths from prescription opioid pills, which will also minimize liability to vendors and prescribers and reduce medication costs

OUR patented VALUE PROPOSITIONS

Established Analgesic

Established Analgesic

Established Analgesic

Our forerunning product, a long-acting buprenorphine injectable suspension, has a clinically proven successful track record of pain management since 2014

Delivery Method

Established Analgesic

Established Analgesic

Our patented lipid carrier system offers a a physician-controlled alternative opioid delivery method, which eliminates pills and limits the potential for abuse  

our traction and projected timeline

Be the First to See Our Leading Asset: PBD-2021

1/7

Download PDF

Contact Us

Drop us a line!

Attach Files
Attachments (0)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Peabody Pharmaceuticals

+1 (713) 858-3329 TTurner@peabodypharma.com

Our Partners

Subscribe

Copyright © 2026 Peabody Pharmaceuticals - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept